Aurora Cannabis (ACB) Cost of Revenue (2017 - 2026)

Aurora Cannabis (ACB) has reported Cost of Revenue for 10 consecutive years, with $27.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 9.08% year-over-year to $27.7 million in Q2 2026; TTM through Jun 2026 was $99.8 million, a 10.95% increase from a year earlier, with the FY2026 full-year figure at $117.1 million, up 12.97% from the prior year.
• Cost of Revenue was $27.7 million for Q2 2026 at Aurora Cannabis, up from -$2.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $110.1 million in Q4 2022 and troughed at -$2.2 million in Q1 2026.
• A 5-year average of $37.0 million and a median of $32.7 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 166.55% in 2022 and plunged 232.49% in 2026, its largest moves.
• Over 5 years, Cost of Revenue stood at $110.1 million in 2022, then sank by 70.8% to $32.2 million in 2023, then dropped by 0.13% to $32.1 million in 2024, then grew by 7.2% to $34.4 million in 2025, then slipped by 19.47% to $27.7 million in 2026.
• The last three Cost of Revenue figures came in at $27.7 million (Q2 2026), -$2.2 million (Q1 2026), and $34.4 million (Q4 2025), per Business Quant data.